Cargando…
Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017
To prevent invasive pneumococcal disease (IPD), pneumococcal conjugate vaccines (PCVs) have been implemented in many countries; however, many cases of IPD still occur and can be attributable to nonvaccine serotypes of Streptococcus pneumoniae. In Japan, the number of IPD cases attributable to seroty...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588537/ https://www.ncbi.nlm.nih.gov/pubmed/33079039 http://dx.doi.org/10.3201/eid2611.200087 |
_version_ | 1783600391935492096 |
---|---|
author | Nakano, Satoshi Fujisawa, Takao Ito, Yutaka Chang, Bin Matsumura, Yasufumi Yamamoto, Masaki Suga, Shigeru Ohnishi, Makoto Nagao, Miki |
author_facet | Nakano, Satoshi Fujisawa, Takao Ito, Yutaka Chang, Bin Matsumura, Yasufumi Yamamoto, Masaki Suga, Shigeru Ohnishi, Makoto Nagao, Miki |
author_sort | Nakano, Satoshi |
collection | PubMed |
description | To prevent invasive pneumococcal disease (IPD), pneumococcal conjugate vaccines (PCVs) have been implemented in many countries; however, many cases of IPD still occur and can be attributable to nonvaccine serotypes of Streptococcus pneumoniae. In Japan, the number of IPD cases attributable to serotype 12F increased from 4.4% in 2015 to 24.6% in 2017 after 13-valent PCV was introduced. To clarify the associated genetic characteristics, we conducted whole-genome sequencing of 75 serotype 12F isolates. We identified 2 sequence types (STs) among the isolates: ST4846, which was the major type, and ST6945. Bayesian analysis suggested that these types diverged in »1942. Among serotype 12F-ST4846, we identified a major cluster, PC-JP12F, whose time of most recent common ancestor was estimated to be »2012. A phylogeographic analysis demonstrated that PC-JP12F isolates spread from the Kanto region, the most populated region in Japan, to other local regions. |
format | Online Article Text |
id | pubmed-7588537 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-75885372020-11-01 Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017 Nakano, Satoshi Fujisawa, Takao Ito, Yutaka Chang, Bin Matsumura, Yasufumi Yamamoto, Masaki Suga, Shigeru Ohnishi, Makoto Nagao, Miki Emerg Infect Dis Research To prevent invasive pneumococcal disease (IPD), pneumococcal conjugate vaccines (PCVs) have been implemented in many countries; however, many cases of IPD still occur and can be attributable to nonvaccine serotypes of Streptococcus pneumoniae. In Japan, the number of IPD cases attributable to serotype 12F increased from 4.4% in 2015 to 24.6% in 2017 after 13-valent PCV was introduced. To clarify the associated genetic characteristics, we conducted whole-genome sequencing of 75 serotype 12F isolates. We identified 2 sequence types (STs) among the isolates: ST4846, which was the major type, and ST6945. Bayesian analysis suggested that these types diverged in »1942. Among serotype 12F-ST4846, we identified a major cluster, PC-JP12F, whose time of most recent common ancestor was estimated to be »2012. A phylogeographic analysis demonstrated that PC-JP12F isolates spread from the Kanto region, the most populated region in Japan, to other local regions. Centers for Disease Control and Prevention 2020-11 /pmc/articles/PMC7588537/ /pubmed/33079039 http://dx.doi.org/10.3201/eid2611.200087 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Nakano, Satoshi Fujisawa, Takao Ito, Yutaka Chang, Bin Matsumura, Yasufumi Yamamoto, Masaki Suga, Shigeru Ohnishi, Makoto Nagao, Miki Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017 |
title | Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017 |
title_full | Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017 |
title_fullStr | Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017 |
title_full_unstemmed | Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017 |
title_short | Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017 |
title_sort | streptococcus pneumoniae serotype 12f-cc4846 and invasive pneumococcal disease after introduction of 13-valent pneumococcal conjugate vaccine, japan, 2015–2017 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588537/ https://www.ncbi.nlm.nih.gov/pubmed/33079039 http://dx.doi.org/10.3201/eid2611.200087 |
work_keys_str_mv | AT nakanosatoshi streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017 AT fujisawatakao streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017 AT itoyutaka streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017 AT changbin streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017 AT matsumurayasufumi streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017 AT yamamotomasaki streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017 AT sugashigeru streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017 AT ohnishimakoto streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017 AT nagaomiki streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017 |